This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Apr 25;297(16):1823-5.

doi: 10.1001/jama.297.16.1823.

Does ranolazine have a place in the treatment of acute coronary syndromes?

L Kristin Newby, Eric D Peterson

PMID: 17456825
DOI: 10.1001/jama.297.16.1823

Editorial

Does ranolazine have a place in the treatment of acute coronary syndromes?

L Kristin Newby et al. JAMA. 2007.

. 2007 Apr 25;297(16):1823-5.

doi: 10.1001/jama.297.16.1823.

Authors

L Kristin Newby, Eric D Peterson

PMID: 17456825
DOI: 10.1001/jama.297.16.1823

No abstract available

PubMed Disclaimer

Comment on

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, Murphy SA, Budaj A, Varshavsky S, Wolff AA, Skene A, McCabe CH, Braunwald E; MERLIN-TIMI 36 Trial Investigators. Morrow DA, et al. JAMA. 2007 Apr 25;297(16):1775-83. doi: 10.1001/jama.297.16.1775. JAMA. 2007. PMID: 17456819 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information